TRPM7 and lung cancer: In essence, we showed that targeting TRPM7 inhibits oncogenic activity, disrupts EMT in favor of the benign epithelial phenotype, inhibit cancer metastasis, attenuate cancer stemness, and increase sensitivity to chemotherapy and potentially results in better prognosis for lung cancer patients.